Ticker Scorecard - FGEN Basics Company: FibroGen, Inc IPO Date: November 14, 2014 Sector: Healthcare Industry: Biotech Market Cap: $71.13M Activated in VL: True Average Daily Range Avg Daily Range: $0.64 | 2.98% Avg Daily Range (30 D): $0.02 | 4.35% Avg Daily Range (90 D): $0.02 | 5.40% Institutional Daily Volume Avg Daily Volume: .89M Avg Daily Volume (30 D): 3.77M Avg Daily Volume (90 D): 2.08M Trade Size Avg Trade Size (Sh.): 136 Avg Trade Size (Sh.) (30 D): 518 Avg Trade Size (Sh.) (90 D): 540 Institutional Trades Total Inst.Trades: 4,014 Avg Inst. Trade: $2.18M Avg Inst. Trade (30 D): $.84M Avg Inst. Trade (90 D): $.84M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.89M Avg Closing Trade (30 D): $9.03M Avg Closing Trade (90 D): $9.03M Avg Closing Volume: 123.42K     News Feb 20, 2025 @ 6:08 PM Amid Mounting Pressure In China, AstraZeneca Buys ... Source: Vandana Singh Sep 2, 2024 @ 8:15 PM Liver Fibrosis Market Is Expected to Reach USD 43.... Source: The Brainy Insights Aug 23, 2024 @ 10:04 PM Catalyst Accelerator Ogden Selects 11 Companies fo... Source: Catalyst Accelerator Ogden Jun 3, 2024 @ 8:48 PM FibroGen Stock Is Surging After The Bell: What's G... Source: Adam Eckert Jun 3, 2024 @ 8:05 PM FibroGen Announces Clinical Trial Supply Agreement... Source: FibroGen, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.23 $-.17 $-.16 Diluted EPS $-1.23 $-.17 $-.16 Revenue $ 180.02M $ 46.33M $ 50.64M Gross Profit $ 138.38M $ 41.04M $ 45.46M Net Income / Loss $ -121.79M $ -17.08M $ -15.54M Operating Income / Loss $ -112.96M $ -16.78M $ -10.92M Cost of Revenue $ 41.63M $ 5.3M $ 5.18M Net Cash Flow $ 8.15M $ -7.75M $ 32.4M PE Ratio